SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹58,462 Cr | ₹52,578 Cr | ₹48,497 Cr | ₹43,886 Cr | ₹38,654 Cr |
What is the latest Revenue of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹58,462 Cr |
| Mar2025 | ₹52,578 Cr |
| Mar2024 | ₹48,497 Cr |
| Mar2023 | ₹43,886 Cr |
| Mar2022 | ₹38,654 Cr |
How is Revenue of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹58,462 Cr | 11.19 | |
| Mar2025 | ₹52,578 Cr | 8.42 | |
| Mar2024 | ₹48,497 Cr | 10.51 | |
| Mar2023 | ₹43,886 Cr | 13.53 | |
| Mar2022 | ₹38,654 Cr | - | |
Compare Revenue of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,704.1 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| MANKIND PHARMA | ₹103,472.0 Cr | -2.4% | 1.2% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.8% |
3.5% |
14.7% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses